Zentalis Pharmaceuticals, Inc. Balance Sheet

Balance Sheet Dec2022 Dec2023 Dec2024
Receivables - Accured 0.51M3.34M2.94M
Assets
Current Assets
Cash & Equivalents 43.07M28.04M33.90M
Receivables - Net 5.00M
Receivables - Other 5.87M
Receivables 5.00M
Prepaid Assets 24.29M20.62M14.40M
Current Assets 451.93M496.72M386.07M
Non-Current Assets
Property, Plant & Equipment (Net) 7.71M5.82M4.70M
Long-Term Investments 21.21M454.88M
Goodwill 3.74M3.74M
Goodwill & Intangibles 3.74M3.74M
Other Non-Current Assets 2.63M6.82M4.42M
Non-Current Assets 87.38M54.97M44.27M
Assets 539.31M551.69M430.34M
Liabilities
Current Liabilities
Accounts Payables 11.25M14.93M7.44M
Payables 11.25M14.93M7.44M
Accumulated Expenses 45.40M54.44M45.29M
Total Current Liabilities 56.65M69.37M52.73M
Non-Current Liabilities
Minority Interest 0.22M0.11M
Operating Leases 45.17M43.15M39.58M
Non-Current Deferred Tax Liability 15.00M10.34M
Other Non-Current Liabilities 2.62M1.78M0.85M
Total Non-Current Liabilities 102.67M112.52M92.30M
Total Liabilities 105.29M114.30M93.15M
Shareholder's Equity
Common Equity 434.02M437.39M337.19M
Shareholder's Equity 434.02M437.39M337.19M
Liabilities and Shareholders Equity 539.31M551.69M430.34M
Retained Earnings -596.37M-888.56M-1054.39M
Treasury Shares 0.92M1.22M2.07M
Shares Outstanding 59.28M70.77M